Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary (Review)

Author：

E-ISSN： 1792-1082|10|2|571-576

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.2, 2015-01, pp. : 571-576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review)

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1163-1173

Spandidos Publications

Access to resources Recommend Favorite

Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)

By Tanase Yasuhito Yamada Yoshihiko Shigetomi Hiroshi Kajihara Hirotaka Oonogi Akira Yoshizawa Yoriko Furukawa Naoto Haruta Shoji Yoshida Shozo Sado Toshiyuki Oi Hidekazu Kobayashi Hiroshi

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 18-24

Spandidos Publications

Access to resources Recommend Favorite

Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 577-597

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Characteristics of Clear Cell Carcinoma of the Ovary

By Behbakht K. Randall T.C. Benjamin I. Morgan M.A. King S. Rubin S.C.

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 255-258

Elsevier

Access to resources Recommend Favorite

Combining DNA Damaging Agents and Checkpoint 1 Inhibitors

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. : 435-438

Bentham Science Publishers

Access to resources Recommend Favorite